EVOKE PHARMA, INC. (NASDAQ:EVOK) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive
EVOKE PHARMA, INC. (NASDAQ:EVOK) Files An 8-K Entry into a Material Definitive AgreementItem 1.01Entry into a Material Definitive Agreement. On November 7, 2017, Evoke Pharma, Inc. (the Company) entered into a Manufacturing Services Agreement (the Manufacturing Agreement) with Patheon UK Limited, a wholly-owned subsidiary of Thermo Fisher, Inc. (Patheon), to which Patheon has agreed to…